Severity
Moderate
FDA Drug recall · Reported October 6, 2021
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Washington Homeopathic Products, Inc. recalled ZTE 1013 Formula Antimicrobial - F&M , Contents 1000 ml, REMEDY: Bryonia Alba 10X, Antimo… - a moderate-severity action.
ZTE 1013 Formula Antimicrobial - F&M , Contents 1000 ml, REMEDY: Bryonia Alba 10X, Antimo… was recalled by Washington Homeopathic Products, Inc. in October 6, 2021. Reason: Out-of-specification test results obtained for identification testing based on HPTLC analysis.. Check the official notice for the remedy. Verify recall #D-0887-2021 with the FDA Drug before acting.
The recall
Washington Homeopathic Products, Inc. issued this moderate-severity FDA Drug recall-Out-of-specification test results obtained for identification testing based on HPTLC analysis..
Sourced from official FDA Drug enforcement records. Verify recall #D-0887-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0887-2021) was formally reported on October 6, 2021, with the manufacturer initiating the action on August 20, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Washington Homeopathic Products, Inc. is listed as the recalling firm, operating out of Berkeley Springs, WV. Federal records list the affected scope as 1 1/liter.
The documented reason for this recall is: Out-of-specification test results obtained for identification testing based on HPTLC analysis. Distribution data in the federal record shows the product reached: Distributed Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1 1/liter
Related Recalls
6
5 from same agency
ZTE 1013 Formula Antimicrobial - F&M , Contents 1000 ml, REMEDY: Bryonia Alba 10X, Antimonium Crudum 10X, Iodium 10X, Lycopodium Clavatum 10X, Pulsatilla 10X, Berberus Vulgaris 10X, Glycyrrhiza Clabra 10X, Condurango 10X, Ginco Biloba 10X, Chromium Sulphuricum 10X, Manganum Metallicum 10X, Zincum Muriaticum 13X, Dilution Alcohol 20%, WHP Homeopathic Medicine, For Manufacturing Use Only; Manufactured for Optimal Health Dimensions, Manufactured by: Washington Homeopathic Products 260 JR Hawvernale Way, Berkeley Springs, WV, 25411,
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0887-2021 |
| Date reported | October 6, 2021 |
| Date initiated | August 20, 2021 |
| Recalling firm | Washington Homeopathic Products, Inc. |
| Firm location | Berkeley Springs, WV |
| Affected scope | 1 1/liter |
| Distribution | Distributed Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 6, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.